Literature DB >> 16189665

Consistent across-tissue signatures of differential gene expression in Crohn's disease.

Austin L Hughes1.   

Abstract

An approach based on analysis of variance was applied to raw expression data on 44,760 transcripts in order to identify those with significant differential expression across ileum and colon in Crohn's disease (CD) and ulcerative colitis (UC). The design treated tissue as a block effect, thereby removing this effect statistically and increasing the power to test for effects of disease states (control, CD, and UC). A significant F-statistic for the disease effect was not correlated with the ratios CD/control or UC/control, evidently because many transcripts with high-expression ratios to the control showed inconsistent patterns across tissues. Of 1,053 transcripts showing a significant effect of disease state at the 1% level by the bootstrap test, 508 showed significant difference at the 1% level in a post hoc test for difference between the mean scores for CD and control. These included a number of genes relevant to the mechanism of pathogenesis of CD and a number of genes mapping to genomic regions that have previously shown linkage to CD in association studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189665      PMCID: PMC1440924          DOI: 10.1007/s00251-005-0044-7

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  26 in total

1.  Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.

Authors:  T B Geijtenbeek; R Torensma; S J van Vliet; G C van Duijnhoven; G J Adema; Y van Kooyk; C G Figdor
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

2.  T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells.

Authors:  Jun-ichi Kashiwakura; Hidenori Yokoi; Hirohisa Saito; Yoshimichi Okayama
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

3.  Discovery and analysis of inflammatory disease-related genes using cDNA microarrays.

Authors:  R A Heller; M Schena; A Chai; D Shalon; T Bedilion; J Gilmore; D E Woolley; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

4.  Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5.

Authors:  S An; Y Zheng; T Bleu
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

5.  Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease.

Authors:  J H Cho; D L Nicolae; R Ramos; C T Fields; K Rabenau; S Corradino; S R Brant; R Espinosa; M LeBeau; S B Hanauer; J Bodzin; D K Bonen
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

6.  Neurokinin-B transcription in erythroid cells: direct activation by the hematopoietic transcription factor GATA-1.

Authors:  Saumen Pal; Michael J Nemeth; David Bodine; Jeffery L Miller; John Svaren; Swee Lay Thein; Philip J Lowry; Emery H Bresnick
Journal:  J Biol Chem       Date:  2004-04-28       Impact factor: 5.157

7.  Gene expression in mononuclear cells from patients with inflammatory bowel disease.

Authors:  Elizabeth E Mannick; Joseph C Bonomolo; Ronald Horswell; Jennifer J Lentz; Maria-Stella Serrano; Adriana Zapata-Velandia; Mariella Gastanaduy; Jessica L Himel; Steven L Rose; John N Udall; Conrad A Hornick; Zhiyun Liu
Journal:  Clin Immunol       Date:  2004-09       Impact factor: 3.969

8.  NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins.

Authors:  Kim D Pruitt; Tatiana Tatusova; Donna R Maglott
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

9.  NCBI GEO: mining millions of expression profiles--database and tools.

Authors:  Tanya Barrett; Tugba O Suzek; Dennis B Troup; Stephen E Wilhite; Wing-Chi Ngau; Pierre Ledoux; Dmitry Rudnev; Alex E Lash; Wataru Fujibuchi; Ron Edgar
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

Review 10.  [What place for DNA microarray in inflammatory diseases?].

Authors:  V Devauchelle; G Chiocchia
Journal:  Rev Med Interne       Date:  2004-10       Impact factor: 0.728

View more
  5 in total

Review 1.  The future of molecular approaches to inflammatory bowel disease.

Authors:  Boyko Kabakchiev; Smita Halder; Mark S Silverberg
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 2.  Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases.

Authors:  Abdulbaqi Al-toma; Petula Nijeboer; Gerd Bouma; Otto Visser; Chris J J Mulder
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 3.  Ets transcription factors in intestinal morphogenesis, homeostasis and disease.

Authors:  Paul Jedlicka; Arthur Gutierrez-Hartmann
Journal:  Histol Histopathol       Date:  2008-11       Impact factor: 2.303

Review 4.  COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges.

Authors:  Iolanda Valentina Popa; Mircea Diculescu; Cătălina Mihai; Cristina Cijevschi-Prelipcean; Alexandru Burlacu
Journal:  Gastroenterol Res Pract       Date:  2020-07-10       Impact factor: 2.260

5.  Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.

Authors:  Andrew M Smith; Farooq Z Rahman; Bu'Hussain Hayee; Simon J Graham; Daniel J B Marks; Gavin W Sewell; Christine D Palmer; Jonathan Wilde; Brian M J Foxwell; Israel S Gloger; Trevor Sweeting; Mark Marsh; Ann P Walker; Stuart L Bloom; Anthony W Segal
Journal:  J Exp Med       Date:  2009-08-03       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.